Edwards Lifesciences United States — Adjustments to goodwill from acquisition remained flat by 0.0% to -$3.78M in Q4 2025 compared to the prior quarter.
Small adjustments are typical during the measurement period; large or frequent adjustments may indicate volatility in acquisition accounting or valuation estimates.
Captures post-acquisition adjustments to the initial goodwill recorded for the United States segment, such as measuremen...
Commonly found in the notes to financial statements for companies with active M&A pipelines.
ew_segment_united_states_adjustments_to_goodwill_from_acquisition| FY'25 | |
|---|---|
| Value | -$15.10M |